Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 17348083)

Published in Stat Med on September 30, 2007

Authors

Gerhard Hommel1, Frank Bretz, Willi Maurer

Author Affiliations

1: University of Mainz, Mainz, Germany. hommel@imbei.uni-mainz.de

Articles by these authors

Simultaneous inference in general parametric models. Biom J (2008) 23.64

Innovative approaches for designing and analyzing adaptive dose-ranging trials. J Biopharm Stat (2007) 4.78

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts. Biom J (2006) 2.61

Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests. Biom J (2011) 2.45

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations. Biom J (2006) 2.16

Experimental designs for small randomised clinical trials: an algorithm for choice. Orphanet J Rare Dis (2013) 1.77

A graphical approach to sequentially rejective multiple test procedures. Stat Med (2009) 1.71

Adaptive Dunnett tests for treatment selection. Stat Med (2008) 1.29

Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology. Stat Med (2009) 1.22

Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests. Stat Med (2008) 1.13

Design and analysis of dose-finding studies combining multiple comparisons and modeling procedures. J Biopharm Stat (2006) 1.08

Power and sample size when multiple endpoints are considered. Pharm Stat (2007) 1.08

Some practical considerations for phase III studies with biomarker evaluations. J Clin Oncol (2014) 1.07

Hierarchical testing of multiple endpoints in group-sequential trials. Stat Med (2010) 1.04

Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures. Stat Med (2011) 0.95

Advanced multiplicity adjustment methods in clinical trials. Stat Med (2013) 0.93

On the efficiency of two-stage response-adaptive designs. Stat Med (2012) 0.93

Efficient two-sample designs for microarray experiments with biological replications. In Silico Biol (2004) 0.92

Model-based dose finding under model uncertainty using general parametric models. Stat Med (2013) 0.91

Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop. J Biopharm Stat (2007) 0.90

Adaptive designs based on the truncated product method. BMC Med Res Methodol (2005) 0.90

Alterations of pre-mRNA splicing in human inflammatory bowel disease. Eur J Cell Biol (2011) 0.88

Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint. Stat Med (2007) 0.88

MR imaging of lung parenchyma at 0.2 T: evaluation of imaging techniques, comparative study with chest radiography and interobserver analysis. Eur Radiol (2004) 0.83

Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim. Pharm Stat (2012) 0.83

Aesthetics and power considerations in multiple testing--a contradiction? Biom J (2008) 0.81

Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics. Biom J (2009) 0.80

Sample size and proportion of Japanese patients in multi-regional trials. Pharm Stat (2010) 0.80

Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussion. J Biopharm Stat (2010) 0.79

Panel forum on multiple comparison procedures: a commentary from a complex trial design and analysis plan. Biom J (2013) 0.78

Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods. Stat Med (2012) 0.77

Multiple hypotheses testing based on ordered p values--a historical survey with applications to medical research. J Biopharm Stat (2011) 0.77

Memory and other properties of multiple test procedures generated by entangled graphs. Stat Med (2012) 0.77

Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians. Biom J (2006) 0.77

Author's reply: To PMID 21837623. Biom J (2013) 0.75

A note on testing families of hypotheses using graphical procedures. Stat Med (2014) 0.75

Normal probability plots with confidence. Biom J (2014) 0.75

Robustness considerations in selecting efficient two-color microarray designs. Bioinformatics (2009) 0.75

Power and sample size computations in simultaneous tests for non-inferiority based on relative margins. Stat Med (2006) 0.75

Dose-response and thresholds in mutagenicity studies: a statistical testing approach. Altern Lab Anim (2003) 0.75

Joint EMA, ISBS, and DR-IBS International Symposium on Biopharmaceutical Statistics: bridging drug development from research to marketing. Stat Med (2013) 0.75

Simultaneous inference for several quantiles of a normal population with applications. Biom J (2012) 0.75

MCP2013 - 8th International Conference on Multiple Comparison Procedures. Biom J (2015) 0.75

MCP2009 - 6(th) International Conference on Multiple Comparison Procedures. Biom J (2010) 0.75